{"id":4303,"date":"2022-08-03T06:51:29","date_gmt":"2022-08-03T06:51:29","guid":{"rendered":"https:\/\/aceoncology.org\/?p=4303"},"modified":"2022-08-03T06:51:31","modified_gmt":"2022-08-03T06:51:31","slug":"adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma","status":"publish","type":"post","link":"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/","title":{"rendered":"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\uff1a\u7597\u6548\u76f8\u4f3c\u3001\u8010\u53d7\u6027\u66f4\u597d"},"content":{"rendered":"\n<p>\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\uff08MM\uff09\u662f\u4e00\u79cd\u897f\u65b9\u7f55\u89c1\uff0c\u4f46\u5728\u4e9a\u6d32\u7b2c\u4e8c\u5e38\u89c1\u7684\u9ed1\u8272\u7d20\u7624\u4e9a\u578b\uff0c\u7ea6\u5360\u6240\u6709\u9ed1\u8272\u7d20\u7624\u7684\u56db\u5206\u4e4b\u4e00\u3002MM \u5177\u6709\u4e0d\u540c\u4e8e\u76ae\u80a4\u9ed1\u8272\u7d20\u7624\u7684\u9057\u4f20\u7279\u5f81\u548c\u751f\u7269\u5b66\u884c\u4e3a\uff0c\u9884\u540e\u66f4\u5dee\uff0c5\u5e74\u751f\u5b58\u7387\u4e3a25%\uff0c\u800c\u76ae\u80a4\u9ed1\u8272\u7d20\u7624\u4e3a80%\u3002\u867d\u7136\u514d\u75ab\u68c0\u67e5\u70b9\u6291\u5236\u5242\uff08ICI\uff0cPD-1\u6291\u5236\u5242\uff09\u8f85\u52a9\u6cbb\u7597\u76ee\u524d\u662f\u76ae\u80a4\u9ed1\u8272\u7d20\u7624\u60a3\u8005\u7684\u6807\u51c6\u6cbb\u7597\uff0c\u4f46\u5c1a\u672a\u786e\u7acb\u5c40\u90e8 MM\u672f\u540e\u7684\u6807\u51c6\u8f85\u52a9\u6cbb\u7597\uff0c\u5b58\u5728\u9ad8\u5ea6\u672a\u6ee1\u8db3\u7684\u9700\u6c42\u3002\u65e2\u5f80\u5728\u65e9\u671f\u9ed1\u8272\u7d20\u7624\uff08\u5305\u62ecMM\uff09\u4e2d\u7684\u8bd5\u9a8c\u663e\u793a\uff0c\u8f85\u52a9\u9ad8\u5242\u91cf\u5e72\u6270\u7d20-\u03b12b\uff08HDI\uff09 \u53ef\u80fd\u6539\u5584\u7ed3\u5c40\u3002\u6b64\u5916\uff0c\u5728\u8f6c\u79fb\u6027 MM \u4e2d\uff0cICI\u4f3c\u4e4e\u6709\u6548\uff0c\u4f46\u4e0d\u5982\u5bf9\u76ae\u80a4\u9ed1\u8272\u7d20\u7624\u6709\u6548\u3002<\/p>\n\n\n\n<p>\u6765\u81ea\u4e2d\u56fd\u7684\u7814\u7a76\u8005\u8fdb\u884c\u4e86\u4e00\u9879<a href=\"https:\/\/www.annalsofoncology.org\/article\/S0923-7534(22)01849-X\/fulltext\"> II \u671f\u968f\u673a\u8bd5\u9a8c<\/a>\uff0c\u5728\u5b8c\u5168\u5207\u9664\u7684 MM \u60a3\u8005\u4e2d\u6bd4\u8f83 HDI \u4e0ePD-1\u6291\u5236\u5242\u7279\u745e\u666e\u5229\u5355\u6297\u3002\u5171\u6709145\u4f8b\u60a3\u8005\u63a5\u53d7HDI\u6216\u7279\u745e\u666e\u5229\u5355\u6297\u6cbb\u75971\u5e74\u6216\u76f4\u81f3\u75be\u75c5\u590d\u53d1\u6216\u51fa\u73b0\u4e0d\u53ef\u8010\u53d7\u7684\u6bd2\u6027\u3002\u60a3\u8005\u5728\u672f\u540e\u4e2d\u4f4d\u5165\u7ec4\u65f6\u95f4\u4e3a14.3\u5468\uff0c\u6839\u636e\u75be\u75c5\u5206\u671f \uff08\u2160-\u2162\u671f\uff09\u3001\u539f\u53d1\u80bf\u7624\u90e8\u4f4d\uff08\u5934\u9888\u90e8\u6216\u975e\u5934\u9888\u90e8\uff09\u548cPD-L1\u8868\u8fbe\u72b6\u6001\u5206\u5c42\u3002\u5934\u9888\u90e8 MM \u60a3\u8005 \uff0839.3%\uff09\u5728\u9996\u6b21\u6cbb\u7597\u540e6-8\u5468\u5185\u540c\u65f6\u63a5\u53d7\u8f85\u52a9\u653e\u7597\u3002\u4e3b\u8981\u7ec8\u70b9\u662f\u6240\u6709\u968f\u673a\u5316\u60a3\u8005\u7684\u65e0\u590d\u53d1\u751f\u5b58\u671f \uff08RFS\uff09\uff0c\u6b21\u8981\u7ec8\u70b9\u5305\u62ec\u65e0\u8fdc\u5904\u8f6c\u79fb\u751f\u5b58\u671f \uff08DMFS\uff09\u3001OS\u548c\u5b89\u5168\u6027\u3002\u5728\u4e2d\u4f4d\u968f\u8bbf26.3\u4e2a\u6708\u65f6\uff0c\u4e24\u7ec4\u7684\u4e2d\u4f4dRFS\u76f8\u4f3c\uff1aHDI\u7ec4\u4e3a13.9\u4e2a\u6708\uff0c\u7279\u745e\u666e\u5229\u5355\u6297\u7ec4\u4e3a13.6\u4e2a\u6708\uff08\u98ce\u9669\u6bd4 [HR]\uff0c1.05\uff1bP = 0.812\uff09\u3002\u6709\u8da3\u7684\u662f\uff0cHDI\u7ec4\u548c\u7279\u745e\u666e\u5229\u5355\u6297\u7ec4PD-L1\u9633\u6027\u60a3\u8005\u7684\u4e2d\u4f4dRFS\u5206\u522b\u4e3a11.1\u4e2a\u6708\u548c17.4\u4e2a\u6708\uff0c\u4f46\u5dee\u5f02\u65e0\u7edf\u8ba1\u5b66\u663e\u8457\u6027\u3002\u540c\u6837\uff0c\u5728\u5176\u4ed6\u4e9a\u7ec4\u4e2d\u672a\u89c2\u5bdf\u5230 RFS \u7684\u663e\u8457\u5dee\u5f02\u3002DMFS \u65e0\u663e\u8457\u5dee\u5f02\uff1aHDI\u7ec4\u4e3a14.6\u4e2a\u6708\uff0c\u7279\u745e\u666e\u5229\u5355\u6297\u7ec4\u4e3a16.3\u4e2a\u6708\uff08HR\uff0c1.00\uff09\u3002HDI \u672a\u8fbe\u5230\u4e2d\u4f4dOS\uff0c\u7279\u745e\u666e\u5229\u5355\u6297\u7ec4\u7684\u4e2d\u4f4d OS \u4e3a35.1\u4e2a\u6708 \uff08HR\uff0c1.1\uff09\u3002\u4f5c\u8005\u63a8\u6d4b\uff0cHDI\u540eICI\u7684\u540e\u7eed\u6cbb\u7597\u53ef\u80fd\u6709\u52a9\u4e8e\u8be5\u7ed3\u679c\u3002\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u7279\u745e\u666e\u5229\u5355\u6297\u7684\u5b89\u5168\u6027\u7279\u5f81\u4f18\u4e8eHDI\u3002HDI\u7ec4\u22653\u7ea7\u6cbb\u7597\u540e\u51fa\u73b0\u7684\u4e0d\u826f\u4e8b\u4ef6 \uff08TEAE\uff09 \u7684\u53d1\u751f\u7387\u8fdc\u9ad8\u4e8e\u7279\u745e\u666e\u5229\u5355\u6297\u7ec4 \uff0887.5% vs. 27.4%\uff09\u3002\u5927\u591a\u6570\u7279\u745e\u666e\u5229\u5355\u6297\u7684TEAE \u4e3a1\u7ea7\u62162\u7ea7\uff0c\u6700\u5e38\u89c1\u7684 TEAE \u4e3a\u4fc3\u7532\u72b6\u817a\u6fc0\u7d20\u6c34\u5e73\u5347\u9ad8 \uff0849.3%\uff09\u3002\u5728\u63a5\u53d7 HDI \u7684\u60a3\u8005\u4e2d\uff0c\u6700\u5e38\u89c1\u7684 TEAE \u662f\u9aa8\u9ad3\u6291\u5236\uff08\u4efb\u4f55\u7b49\u7ea7\uff1a98.6%\uff1b\u22653\u7ea7\uff1a59.7%\uff09\u3002\u6b64\u5916\uff0cHDI\u4e0e\u53d1\u70ed\u548c\u809d\u8f6c\u6c28\u9176\u5347\u9ad8\u7684\u53d1\u751f\u7387\u8f83\u9ad8\u76f8\u5173\u3002\u4e24\u7ec4\u4e2d\u56e0 TEAE \u5bfc\u81f4\u7684\u6cbb\u7597\u4e2d\u6b62\u53d1\u751f\u7387\u76f8\u4f3c\uff08\u7ea68%\uff09\uff0c\u4f46 HDI \u7ec4\u4e2d\u7ed9\u836f\u5ef6\u8fdf\u66f4\u5e38\u89c1\uff0820.8%\u4e0e13.7%\uff09\uff0c\u672a\u53d1\u751f\u6cbb\u7597\u76f8\u5173\u6b7b\u4ea1\u6216\u8f93\u6db2\u53cd\u5e94\u3002<\/p>\n\n\n\n<p>\u4f5c\u8005\u5199\u9053\uff1a\u201c\u7279\u745e\u666e\u5229\u5355\u6297\u6bd4 HDI \u5177\u6709\u66f4\u6709\u5229\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\u7279\u5f81\uff0c\u8868\u660e\u7279\u745e\u666e\u5229\u5355\u6297\u53ef\u80fd\u662f\u66f4\u597d\u7684\u6cbb\u7597\u9009\u62e9\u3002\u201d\u7136\u800c\uff0c\u4ed6\u4eec\u627f\u8ba4\u4e86\u8be5\u7814\u7a76\u7684\u51e0\u4e2a\u5c40\u9650\u6027\uff0c\u5e76\u8bc4\u8bba\u9700\u8981\u989d\u5916\u7684\u8f6c\u5316\u7814\u7a76\u548c\u751f\u7269\u6807\u5fd7\u7269\u7814\u7a76\u6765\u8bc1\u5b9e\u4ed6\u4eec\u7684\u53d1\u73b0\uff0c\u5e76\u8fdb\u4e00\u6b65\u4f18\u5316\u7279\u745e\u666e\u5229\u5355\u6297\u65b9\u6848\u3002<\/p>\n\n\n\n<p><strong>\u53c2\u8003\u6587\u732e<\/strong><\/p>\n\n\n\n<p>Lian B, et al. <em>Ann Oncol.<\/em> 2022, July 13 [Online ahead of print].<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\uff08MM\uff09\u662f\u4e00\u79cd\u897f\u65b9\u7f55\u89c1\uff0c\u4f46\u5728\u4e9a\u6d32\u7b2c\u4e8c\u5e38\u89c1\u7684\u9ed1\u8272\u7d20\u7624\u4e9a\u578b\uff0c\u7ea6\u5360\u6240\u6709\u9ed1\u8272\u7d20\u7624\u7684\u56db\u5206\u4e4b\u4e00\u3002MM \u5177\u6709\u4e0d\u540c [&hellip;]<\/p>\n","protected":false},"author":691,"featured_media":4281,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-4303","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\uff1a\u7597\u6548\u76f8\u4f3c\u3001\u8010\u53d7\u6027\u66f4\u597d - ACE Oncology<\/title>\n<meta name=\"description\" content=\"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\u5177\u6709\u76f8\u4f3c\u7684\u7597\u6548\u3001\u66f4\u9ad8\u7684\u8010\u53d7\u6027\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\uff1a\u7597\u6548\u76f8\u4f3c\u3001\u8010\u53d7\u6027\u66f4\u597d - ACE Oncology\" \/>\n<meta property=\"og:description\" content=\"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\u5177\u6709\u76f8\u4f3c\u7684\u7597\u6548\u3001\u66f4\u9ad8\u7684\u8010\u53d7\u6027\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/\" \/>\n<meta property=\"og:site_name\" content=\"ACE Oncology\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-03T06:51:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-03T06:51:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-96-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1193\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"j gao\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:site\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"j gao\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/\"},\"author\":{\"name\":\"j gao\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf\"},\"headline\":\"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\uff1a\u7597\u6548\u76f8\u4f3c\u3001\u8010\u53d7\u6027\u66f4\u597d\",\"datePublished\":\"2022-08-03T06:51:29+00:00\",\"dateModified\":\"2022-08-03T06:51:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/\"},\"wordCount\":63,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-96-scaled.jpg\",\"articleSection\":[\"\u6587\u7ae0\u7cbe\u8981\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/\",\"url\":\"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/\",\"name\":\"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\uff1a\u7597\u6548\u76f8\u4f3c\u3001\u8010\u53d7\u6027\u66f4\u597d - ACE Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-96-scaled.jpg\",\"datePublished\":\"2022-08-03T06:51:29+00:00\",\"dateModified\":\"2022-08-03T06:51:31+00:00\",\"description\":\"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\u5177\u6709\u76f8\u4f3c\u7684\u7597\u6548\u3001\u66f4\u9ad8\u7684\u8010\u53d7\u6027\",\"breadcrumb\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#primaryimage\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-96-scaled.jpg\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-96-scaled.jpg\",\"width\":2560,\"height\":1193},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"ACE Oncology\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\uff1a\u7597\u6548\u76f8\u4f3c\u3001\u8010\u53d7\u6027\u66f4\u597d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/aceoncology.org\/#website\",\"url\":\"https:\/\/aceoncology.org\/\",\"name\":\"ACE Oncology\",\"description\":\"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.\",\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/aceoncology.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/aceoncology.org\/#organization\",\"name\":\"ACE Oncology\",\"url\":\"https:\/\/aceoncology.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"width\":156,\"height\":83,\"caption\":\"ACE Oncology\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ace_oncology\",\"https:\/\/www.linkedin.com\/company\/aceoncology\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf\",\"name\":\"j gao\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g\",\"caption\":\"j gao\"},\"url\":\"https:\/\/aceoncology.org\/zh-hans\/author\/jgao\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\uff1a\u7597\u6548\u76f8\u4f3c\u3001\u8010\u53d7\u6027\u66f4\u597d - ACE Oncology","description":"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\u5177\u6709\u76f8\u4f3c\u7684\u7597\u6548\u3001\u66f4\u9ad8\u7684\u8010\u53d7\u6027","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/","og_locale":"zh_CN","og_type":"article","og_title":"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\uff1a\u7597\u6548\u76f8\u4f3c\u3001\u8010\u53d7\u6027\u66f4\u597d - ACE Oncology","og_description":"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\u5177\u6709\u76f8\u4f3c\u7684\u7597\u6548\u3001\u66f4\u9ad8\u7684\u8010\u53d7\u6027","og_url":"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/","og_site_name":"ACE Oncology","article_published_time":"2022-08-03T06:51:29+00:00","article_modified_time":"2022-08-03T06:51:31+00:00","og_image":[{"width":2560,"height":1193,"url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-96-scaled.jpg","type":"image\/jpeg"}],"author":"j gao","twitter_card":"summary_large_image","twitter_creator":"@ace_oncology","twitter_site":"@ace_oncology","twitter_misc":{"\u4f5c\u8005":"j gao","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#article","isPartOf":{"@id":"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/"},"author":{"name":"j gao","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf"},"headline":"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\uff1a\u7597\u6548\u76f8\u4f3c\u3001\u8010\u53d7\u6027\u66f4\u597d","datePublished":"2022-08-03T06:51:29+00:00","dateModified":"2022-08-03T06:51:31+00:00","mainEntityOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/"},"wordCount":63,"commentCount":0,"publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-96-scaled.jpg","articleSection":["\u6587\u7ae0\u7cbe\u8981"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/","url":"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/","name":"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\uff1a\u7597\u6548\u76f8\u4f3c\u3001\u8010\u53d7\u6027\u66f4\u597d - ACE Oncology","isPartOf":{"@id":"https:\/\/aceoncology.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#primaryimage"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-96-scaled.jpg","datePublished":"2022-08-03T06:51:29+00:00","dateModified":"2022-08-03T06:51:31+00:00","description":"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\u5177\u6709\u76f8\u4f3c\u7684\u7597\u6548\u3001\u66f4\u9ad8\u7684\u8010\u53d7\u6027","breadcrumb":{"@id":"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#primaryimage","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-96-scaled.jpg","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/07\/Blog-Post-Picture-96-scaled.jpg","width":2560,"height":1193},{"@type":"BreadcrumbList","@id":"https:\/\/aceoncology.org\/zh-hans\/adjuvant-toripalimab-vs-high-dose-interferon-in-mucosal-melanoma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"ACE Oncology","item":"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/"},{"@type":"ListItem","position":2,"name":"\u7279\u745e\u666e\u5229\u5355\u6297\u8f85\u52a9\u6cbb\u7597\u5bf9\u6bd4\u9ad8\u5242\u91cf\u5e72\u6270\u7d20\u6cbb\u7597\u9ecf\u819c\u9ed1\u8272\u7d20\u7624\uff1a\u7597\u6548\u76f8\u4f3c\u3001\u8010\u53d7\u6027\u66f4\u597d"}]},{"@type":"WebSite","@id":"https:\/\/aceoncology.org\/#website","url":"https:\/\/aceoncology.org\/","name":"ACE Oncology","description":"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.","publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aceoncology.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/aceoncology.org\/#organization","name":"ACE Oncology","url":"https:\/\/aceoncology.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","width":156,"height":83,"caption":"ACE Oncology"},"image":{"@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ace_oncology","https:\/\/www.linkedin.com\/company\/aceoncology"]},{"@type":"Person","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf","name":"j gao","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g","caption":"j gao"},"url":"https:\/\/aceoncology.org\/zh-hans\/author\/jgao\/"}]}},"_links":{"self":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/4303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/users\/691"}],"replies":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/comments?post=4303"}],"version-history":[{"count":1,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/4303\/revisions"}],"predecessor-version":[{"id":4304,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/4303\/revisions\/4304"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media\/4281"}],"wp:attachment":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=4303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/categories?post=4303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/tags?post=4303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}